$LGND Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in LIGAND PHARMACEUTICALS INC. Get notifications about new insider transactions in LIGAND PHARMACEUTICALS INC for free.

Page:   < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 15 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 14 2014LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS74.501,00074,50029,64530.6 K to 29.6 K (-3.26 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM16.141,00016,14030,64529.6 K to 30.6 K (+3.37 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS74.501,16686,86729,64530.8 K to 29.6 K (-3.78 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM21.001,16624,48630,81129.6 K to 30.8 K (+3.93 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS74.5038628,75729,64530 K to 29.6 K (-1.29 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM42.9038616,55930,03129.6 K to 30 K (+1.30 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.002,500029,64527.1 K to 29.6 K (+9.21 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseM9.9616,875168,07548,125
Feb 14 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseA74.4210,000744,20095,000
Feb 14 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseA74.4210,000744,20085,000
Feb 14 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseA74.4275,0005,581,50075,000
Feb 14 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOGrantA0.008,0000119,099111.1 K to 119.1 K (+7.20 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOSellS75.0016,8751,265,625111,099128 K to 111.1 K (-13.19 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOBuyM9.9616,875168,075127,974111.1 K to 128 K (+15.19 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOOption ExerciseA74.4210,000744,20065,000
Feb 14 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOOption ExerciseA74.4210,000744,20055,000
Feb 14 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOOption ExerciseA74.4245,0003,348,90045,000
Feb 14 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOOption ExerciseM9.9722,500224,325133,056
Feb 14 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOOption ExerciseM9.973,44434,337155,556
Feb 14 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOSellS79.5422,5001,789,65053,45776 K to 53.5 K (-29.62 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOBuyM9.9722,500224,32575,95753.5 K to 76 K (+42.09 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOBuyM9.973,44434,33753,45750 K to 53.5 K (+6.89 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOGrantA0.005,000050,01345 K to 50 K (+11.11 %)
Feb 14 2014LGNDLIGAND PHARMACEUTI ...DeSilva Nishan MVP, Corporate Devel ...Option ExerciseA74.425,000372,10045,000
Feb 14 2014LGNDLIGAND PHARMACEUTI ...DeSilva Nishan MVP, Corporate Devel ...Option ExerciseA74.425,000372,10040,000
Feb 14 2014LGNDLIGAND PHARMACEUTI ...DeSilva Nishan MVP, Corporate Devel ...Option ExerciseA74.4235,0002,604,70035,000
Feb 14 2014LGNDLIGAND PHARMACEUTI ...DeSilva Nishan MVP, Corporate Devel ...GrantA0.003,000018,65915.7 K to 18.7 K (+19.16 %)
Jan 21 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseM21.009,000189,00028,483
Jan 21 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOBuyM21.009,000189,000111,099102.1 K to 111.1 K (+8.81 %)
Jan 21 2014LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOSellS64.0015,000960,000102,099117.1 K to 102.1 K (-12.81 %)
Jan 02 2014LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOBuyP33.92842,84945,01344.9 K to 45 K (+0.19 %)
Jan 02 2014LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyP33.922097,08827,14526.9 K to 27.1 K (+0.78 %)
Dec 16 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOOption ExerciseM9.967006,9727,842
Dec 16 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOSellS53.4470037,40817,66718.4 K to 17.7 K (-3.81 %)
Dec 16 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOBuyM9.967006,97218,36717.7 K to 18.4 K (+3.96 %)
Dec 13 2013LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOOption ExerciseM9.976,00059,820159,000
Dec 13 2013LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOSellS53.406,000320,40044,92950.9 K to 44.9 K (-11.78 %)
Dec 13 2013LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOBuyM9.976,00059,82050,92944.9 K to 50.9 K (+13.35 %)
Dec 09 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOSellS56.086,000336,48017,66723.7 K to 17.7 K (-25.35 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.07154,5788,822,4932,008,8342.2 M to 2 M (-7.15 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.0727,0581,544,327101,523128.6 K to 101.5 K (-21.04 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.0750,9342,907,043190,967241.9 K to 191 K (-21.06 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.0786,4354,933,252324,836411.3 K to 324.8 K (-21.02 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.5734,9172,010,172128,581163.5 K to 128.6 K (-21.36 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.5754,4443,134,341241,901296.3 K to 241.9 K (-18.37 %)
Nov 29 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS57.57119,1396,858,832411,271530.4 K to 411.3 K (-22.46 %)
Nov 21 2013LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGiftG0.003,800021,35625.2 K to 21.4 K (-15.11 %)
Nov 27 2013LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorOption ExerciseM7.406134,5360
Nov 27 2013LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorOption ExerciseM6.826304,2970
Nov 27 2013LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorBuyM6.826304,29742,96942.3 K to 43 K (+1.49 %)
Nov 27 2013LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorBuyM7.406134,53642,33941.7 K to 42.3 K (+1.47 %)
Nov 20 2013LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorOption ExerciseM14.864606,8360
Nov 20 2013LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorBuyM14.864606,83641,72641.3 K to 41.7 K (+1.11 %)
Nov 20 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOOption ExerciseM9.966246,2158,542
Nov 20 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOSellS53.001,12359,51923,66724.8 K to 23.7 K (-4.53 %)
Nov 20 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOBuyM9.966246,21524,79024.2 K to 24.8 K (+2.58 %)
Oct 22 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseM21.005,850122,85037,483
Oct 22 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseM10.054,66846,91315,675
Oct 22 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOBuyM10.054,66846,913117,099112.4 K to 117.1 K (+4.15 %)
Oct 22 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOBuyM21.005,850122,850112,431106.6 K to 112.4 K (+5.49 %)
Oct 22 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOSellS55.0010,000550,000106,581116.6 K to 106.6 K (-8.58 %)
Sep 25 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS44.50147,8066,577,367296,345444.2 K to 296.3 K (-33.28 %)
Sep 25 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerSellS44.50211,2179,399,157530,410741.6 K to 530.4 K (-28.48 %)
Sep 13 2013LGNDLIGAND PHARMACEUTI ...KNOTT DAVID MDirectorSellS46.78160,0007,484,08051,396211.4 K to 51.4 K (-75.69 %)
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM21.003,83480,5140
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM21.009,499199,4793,834
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM16.144,86278,4730
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM16.1411,804190,5174,862
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM14.477,020101,5792,850
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM10.053123,1365,625
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM10.053123,13626,93626.6 K to 26.9 K (+1.17 %)
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM16.144,86278,47326,62421.8 K to 26.6 K (+22.34 %)
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM21.003,83480,51421,76217.9 K to 21.8 K (+21.39 %)
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS47.547,020333,72617,92824.9 K to 17.9 K (-28.14 %)
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM14.477,020101,57924,94817.9 K to 24.9 K (+39.16 %)
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS47.5411,804561,15417,92829.7 K to 17.9 K (-39.70 %)
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM16.1411,804190,51729,73217.9 K to 29.7 K (+65.84 %)
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS47.549,499451,57617,92827.4 K to 17.9 K (-34.63 %)
Sep 04 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM21.009,499199,47927,42717.9 K to 27.4 K (+52.98 %)
Aug 20 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOOption ExerciseM9.967,50074,7009,166
Aug 20 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOSellS42.757,500320,61924,16631.7 K to 24.2 K (-23.68 %)
Aug 20 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOBuyM9.967,50074,70031,66624.2 K to 31.7 K (+31.04 %)
Aug 20 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM9.9614,583145,2472,083
Aug 20 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseM10.054,28443,0545,937
Aug 20 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM10.054,28443,05417,92813.6 K to 17.9 K (+31.40 %)
Aug 20 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS42.6314,583621,73213,64428.2 K to 13.6 K (-51.66 %)
Aug 20 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyM9.9614,583145,24728,22713.6 K to 28.2 K (+106.88 %)
Aug 20 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseM16.146,556105,81458,444
Aug 20 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOBuyM16.146,556105,814116,581110 K to 116.6 K (+5.96 %)
Aug 20 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOSellS42.8510,000428,500110,025120 K to 110 K (-8.33 %)
Jul 01 2013LGNDLIGAND PHARMACEUTI ...DeSilva Nishan MVP, Corporate Devel ...BuyP17.361692,93415,65915.5 K to 15.7 K (+1.09 %)
Jul 01 2013LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOBuyP17.361,05918,38444,92943.9 K to 44.9 K (+2.41 %)
Jul 01 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyP17.3681514,14813,64412.8 K to 13.6 K (+6.35 %)
Jun 13 2013LGNDLIGAND PHARMACEUTI ...Sabba Stephen LDirectorOption ExerciseA32.307,335236,9217,335
Jun 13 2013LGNDLIGAND PHARMACEUTI ...Sabba Stephen LDirectorGrantA0.003,621021,04617.4 K to 21 K (+20.78 %)
Jun 13 2013LGNDLIGAND PHARMACEUTI ...KNOTT DAVID MDirectorOption ExerciseA32.307,335236,9217,335
Jun 13 2013LGNDLIGAND PHARMACEUTI ...KNOTT DAVID MDirectorGrantA0.004,318063,74359.4 K to 63.7 K (+7.27 %)
Jun 12 2013LGNDLIGAND PHARMACEUTI ...Patel SunilDirectorOption ExerciseA32.307,335236,9217,335
Jun 12 2013LGNDLIGAND PHARMACEUTI ...Patel SunilDirectorGrantA0.001,393040,54039.1 K to 40.5 K (+3.56 %)
Jun 12 2013LGNDLIGAND PHARMACEUTI ...Patel SunilDirectorGrantA0.002,925039,14736.2 K to 39.1 K (+8.08 %)
Jun 12 2013LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorOption ExerciseA32.307,335236,9217,335
Jun 12 2013LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.00696025,15624.5 K to 25.2 K (+2.85 %)
Jun 12 2013LGNDLIGAND PHARMACEUTI ...LAMATTINA JOHN LDirectorGrantA0.002,925024,46021.5 K to 24.5 K (+13.58 %)
Jun 12 2013LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorOption ExerciseA32.307,335236,9217,335
Jun 12 2013LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorGrantA0.001,393041,26639.9 K to 41.3 K (+3.49 %)
Jun 12 2013LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorGrantA0.002,925039,87336.9 K to 39.9 K (+7.92 %)
Jun 12 2013LGNDLIGAND PHARMACEUTI ...Davis Todd CDirectorOption ExerciseA32.307,335236,9217,335
Jun 12 2013LGNDLIGAND PHARMACEUTI ...Davis Todd CDirectorGrantA0.001,393040,03638.6 K to 40 K (+3.60 %)
Jun 12 2013LGNDLIGAND PHARMACEUTI ...Davis Todd CDirectorGrantA0.002,925038,64335.7 K to 38.6 K (+8.19 %)
Jun 12 2013LGNDLIGAND PHARMACEUTI ...Aryeh JasonDirectorOption ExerciseA32.307,335236,9217,335
Jun 12 2013LGNDLIGAND PHARMACEUTI ...Aryeh JasonDirectorGrantA0.002,925031,24328.3 K to 31.2 K (+10.33 %)
Jun 04 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseA32.0014,334458,68814,334
Jun 04 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOGrantA0.0012,0000120,025108 K to 120 K (+11.11 %)
Jun 04 2013LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOGrantA0.008,333043,87035.5 K to 43.9 K (+23.45 %)
May 13 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS26.664,000106,64012,82916.8 K to 12.8 K (-23.77 %)
Feb 19 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseA21.9215,144331,95615,144
Feb 19 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...Option ExerciseA21.924,856106,4444,856
Feb 19 2013LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...GrantA0.002,500016,82914.3 K to 16.8 K (+17.45 %)
Feb 19 2013LGNDLIGAND PHARMACEUTI ...DeSilva Nishan MVP, Corporate Devel ...Option ExerciseA21.9240,626890,52240,626
Feb 19 2013LGNDLIGAND PHARMACEUTI ...DeSilva Nishan MVP, Corporate Devel ...Option ExerciseA21.924,37495,8784,374
Feb 19 2013LGNDLIGAND PHARMACEUTI ...DeSilva Nishan MVP, Corporate Devel ...GrantA0.005,000015,49010.5 K to 15.5 K (+47.66 %)
Feb 19 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseA21.9295,6162,095,90395,616
Feb 19 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOOption ExerciseA21.9211,384249,53711,384
Feb 19 2013LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOGrantA0.008,0000120,025112 K to 120 K (+7.14 %)
Feb 19 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOOption ExerciseA21.9215,568341,25115,568
Feb 19 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOOption ExerciseA21.924,43297,1494,432
Feb 19 2013LGNDLIGAND PHARMACEUTI ...Sharp John PVP Finance and CFOGrantA0.002,500024,16621.7 K to 24.2 K (+11.54 %)
Feb 19 2013LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOOption ExerciseA21.9264,6251,416,58064,625
Feb 19 2013LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOOption ExerciseA21.928,375183,5808,375
Feb 19 2013LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOGrantA0.006,000043,87037.9 K to 43.9 K (+15.84 %)
Jan 25 2013LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerBuyP19.7839,600783,1812,163,4122.1 M to 2.2 M (+1.86 %)
Jan 03 2013LGNDLIGAND PHARMACEUTI ...DeSilva Nishan MVP, Corporate Devel ...BuyJ14.544907,12210,49010 K to 10.5 K (+4.90 %)
Dec 21 2012LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorBuyM12.063,33340,19636,94833.6 K to 36.9 K (+9.92 %)
Dec 18 2012LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerBuyP18.635,386100,3652,123,8122.1 M to 2.1 M (+0.25 %)
Dec 10 2012LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerBuyP17.9450,100898,9592,118,4262.1 M to 2.1 M (+2.42 %)
Dec 05 2012LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOBuyP18.032,00036,060112,025110 K to 112 K (+1.82 %)
Dec 05 2012LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOBuyP17.993706,65637,87037.5 K to 37.9 K (+0.99 %)
Dec 03 2012LGNDLIGAND PHARMACEUTI ...KNOTT DAVID MDirectorSellS19.716,652131,111211,396218 K to 211.4 K (-3.05 %)
Dec 03 2012LGNDLIGAND PHARMACEUTI ...KNOTT DAVID MDirectorSellS20.0013,348266,960218,048231.4 K to 218 K (-5.77 %)
Nov 29 2012LGNDLIGAND PHARMACEUTI ...KNOTT DAVID MDirectorSellS19.5135,000682,850231,396266.4 K to 231.4 K (-13.14 %)
Nov 29 2012LGNDLIGAND PHARMACEUTI ...KNOTT DAVID MDirectorSellS19.5565,0001,270,750266,396331.4 K to 266.4 K (-19.61 %)
Nov 15 2012LGNDLIGAND PHARMACEUTI ...KNOTT DAVID MDirectorBuyP16.362,74344,8752,7430 to 2.7 K
Nov 02 2012LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerBuyP14.994,07661,096741,627737.6 K to 741.6 K (+0.55 %)
Nov 02 2012LGNDLIGAND PHARMACEUTI ...BVF PARTNERS L P/IL10% OwnerBuyP15.2612,515190,926737,551725 K to 737.6 K (+1.73 %)
Sep 05 2012LGNDLIGAND PHARMACEUTI ...KNOTT DAVID MDirectorSellJ0.0041,5830041.6 K to 0 (-100.00 %)
Sep 10 2012LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...SellS18.774,24979,75414,32918.6 K to 14.3 K (-22.87 %)
Aug 14 2012LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOBuyP16.395008,195110,025109.5 K to 110 K (+0.46 %)
Jul 03 2012LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LPresident & CEOBuyJ10.121,25012,654109,525108.3 K to 109.5 K (+1.15 %)
Jul 03 2012LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WEVP and COOBuyJ10.121,25012,65437,50036.3 K to 37.5 K (+3.45 %)
Jul 03 2012LGNDLIGAND PHARMACEUTI ...Berkman Charles SVP, Gen. Counsel & ...BuyJ10.121,25012,65418,57817.3 K to 18.6 K (+7.21 %)

Page:   < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 15 next >

Contact us | Follow us on Twitter